RAMP2 (receptor activity modifying protein 2)

2007-11-01  

Identity

HGNC
LOCATION
17q21.2
LOCUSID
ALIAS
-
FUSION GENES

Other Information

Locus ID:

NCBI: 10266
MIM: 605154
HGNC: 9844
Ensembl: ENSG00000131477

Variants:

dbSNP: 10266
ClinVar: 10266
TCGA: ENSG00000131477
COSMIC: RAMP2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000131477ENST00000253796O60895
ENSG00000131477ENST00000253796A0A024R1Z2
ENSG00000131477ENST00000587142O60895
ENSG00000131477ENST00000588576K7EKQ3
ENSG00000131477ENST00000588928K7ENJ8
ENSG00000131477ENST00000589683K7EPN3

Expression (GTEx)

0
50
100
150
200
250
300

Pathways

PathwaySourceExternal ID
Vascular smooth muscle contractionKEGGhsa04270
Vascular smooth muscle contractionKEGGko04270
Signal TransductionREACTOMER-HSA-162582
Signaling by GPCRREACTOMER-HSA-372790
GPCR ligand bindingREACTOMER-HSA-500792
Class B/2 (Secretin family receptors)REACTOMER-HSA-373080
Calcitonin-like ligand receptorsREACTOMER-HSA-419812
GPCR downstream signalingREACTOMER-HSA-388396
G alpha (s) signalling eventsREACTOMER-HSA-418555

References

Pubmed IDYearTitleCitations
382795012023RAMP2-AS1 stabilized RAPM2 mRNA through TIA1 to inhibit the progression of non-small cell lung cancer.0
382795012023RAMP2-AS1 stabilized RAPM2 mRNA through TIA1 to inhibit the progression of non-small cell lung cancer.0
333853432021Adrenomedullin-Receptor Activity-Modifying Protein 2 System Ameliorates Subretinal Fibrosis by Suppressing Epithelial-Mesenchymal Transition in Age-Related Macular Degeneration.3
342712202021Receptor Activity-Modifying Protein 2 (RAMP2) alters glucagon receptor trafficking in hepatocytes with functional effects on receptor signalling.14
333853432021Adrenomedullin-Receptor Activity-Modifying Protein 2 System Ameliorates Subretinal Fibrosis by Suppressing Epithelial-Mesenchymal Transition in Age-Related Macular Degeneration.3
342712202021Receptor Activity-Modifying Protein 2 (RAMP2) alters glucagon receptor trafficking in hepatocytes with functional effects on receptor signalling.14
308262862019Interactions between RAMP2 and CRF receptors: The effect of receptor subtypes, splice variants and cell context.11
311504172019Development of chimeric and bifunctional antagonists for CLR/RAMP receptors.9
308262862019Interactions between RAMP2 and CRF receptors: The effect of receptor subtypes, splice variants and cell context.11
311504172019Development of chimeric and bifunctional antagonists for CLR/RAMP receptors.9
285864392017RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling.18
286146672017N-Glycosylation of Asparagine 130 in the Extracellular Domain of the Human Calcitonin Receptor Significantly Increases Peptide Hormone Affinity.11
289042532017Genetic Variants of RAMP2 and CLR are Associated with Stroke.9
285864392017RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling.18
286146672017N-Glycosylation of Asparagine 130 in the Extracellular Domain of the Human Calcitonin Receptor Significantly Increases Peptide Hormone Affinity.11

Citation

Dessen P

RAMP2 (receptor activity modifying protein 2)

Atlas Genet Cytogenet Oncol Haematol. 2007-11-01

Online version: http://atlasgeneticsoncology.org/gene/49831/welcome